Medical device manufacturer eliminates paper-based Device History Records, cutting documentation time from two weeks to real time while strengthening audit readiness
Cartago, Costa Rica, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Biomerics, a leading contract manufacturer of medical devices, has completed an extensive validation process and gone live with Eyelit Technologies'Manufacturing Execution System (Eyelit MES), including full electronic Device History Record (eDHR) functionality. The go-live achieves the original goals of the project and marks a significant step toward fully compliant, paperless production at Biomerics' Costa Rica operations.
Prior to implementation, Biomerics relied on paper-based DHRs that could run 100 to 500 pages per record and take up to two weeks to compile, tying up resources that could otherwise support the production floor. With Eyelit MES now live, that manual compilation burden is gone, freeing staff to focus on production while reducing the risk of documentation errors.
Compliance is now built into the manufacturing process itself rather than handled as a separate post-production step, and an immutable blockchain record of production data, backed by compliant electronic signatures, reinforces conformance with ISO 13485, 21 CFR Part 11 and 21 CFR Part 820/QMSR. Validation is managed within the same system used for production, giving Biomerics a single auditable record rather than a parallel paper trail, and staff time once spent on documentation and post-production verification is now available for continuous improvement.
The Biomerics go-live reflects Eyelit's broader Manufacturing Operations Management (MOM) approach, in which MES serves as the foundation for further expansion into planning, scheduling, and execution improvements powered by Agent EyeQ, giving manufacturers a single platform to grow into as operations mature.
About Eyelit Technologies
Eyelit Technologies is a leading provider of integrated software solutions that optimize factory and multi-factory productivity across industries such as semiconductor, automotive, medical device, electronics, and aerospace & defense. Its AI-powered suite of planning, scheduling, and execution solutions enables businesses to improve production processes, enhance asset utilization, and streamline scheduling. Eyelit Technologies empowers organizations to drive profitable growth, reduce costs, improve delivery performance, and gain greater visibility, improved decision support, and decision execution.
Expanding on this foundation, Eyelit's purpose-built, industry-specific solutions extend the capabilities of existing platforms to optimize decision-making across supply chain, planning, and execution. These tailored solutions improve outcomes by addressing critical elements such as orders, quality, assets, materials, labor, and suppliers. To learn more, visit: www.eyelit.com
About Biomerics
Founded in 1994, Biomerics is a leading vertically integrated contract development and manufacturing organization serving the global interventional medical device market. As a trusted strategic partner to 20 of the world's top 30 medical device OEMs, Biomerics helps customers accelerate innovation, reduce complexity and bring life-changing technologies to market.
Biomerics provides end-to-end capabilities spanning engineering design and development, technology transfer, manufacturing, sterilization, packaging, and commercialization of medical device components, subassemblies and finished devices. Through an integrated network of 12 manufacturing facilities across the United States, Costa Rica and the Dominican Republic, the company delivers scalable solutions that support customers from concept through commercial production.
With world-class engineering Centers of Excellence, Biomerics is a recognized leader in advanced polymers and materials, precision extrusion, balloons and balloon catheters, advanced catheters and steerables, guidewires, laser processing, micromachining, micro-overmolding, precision stamping, metal injection molding (MIM), image-guided intervention technologies, complex microassembly, and finished device manufacturing.
Operating under a certified ISO 13485:2016 Quality Management System and compliant with applicable FDA medical device regulations, Biomerics is committed to improving and saving lives by delivering exceptional customer experiences, advancing innovation and achieving manufacturing excellence.
Contact:
Johanna Coutinho
Eyelit Technologies
6478810894
jcoutinho@eyelit.com
-
昱能科技亮相第140届广交会&捷克智慧能源展,加速拓展海内外光储市场广州和布拉格2026年10月16日 美通社 -- 近日,两大国际盛会第140届广交会与2026捷克国际智慧能源展盛大举行。昱能科技凭借其在光伏+储能领域的深厚积累与创新技术,携2026-10-16
-
大金启动老客户住宅空气升级服务2026秋季在智能化时代与“双碳”目标背景下,空调行业头部品牌大金积极布局存量市场,引领行业从“单一设备销售”向“全生命周期空气服务”跨越。2026年秋季,大金正2026-10-16
-
中科时代×ISG发布智能CNC一体化解决方案,软硬一体开箱即用中科时代×ISG发布智能CNC一体化解决方案,软硬一体开箱即用2026-10-16
-
数据中心消防安全升级:红外热成像+AI将预警窗口前移至温升阶段随着算力需求的快速增长,数据中心已成为数字经济的关键基础设施。其设备密集、长期高负载运行,电气火灾风险隐蔽、后果严重:轻则设备损毁,重则业务中断、数据丢失、公2026-10-16
-
日本阿明诺AHCC®亮相2026 ASCO:聚焦国际临床研究与中国市场官方授权体系近日,日本原研营养品牌AHCC®相关临床研究成果亮相2026年美国临床肿瘤学会(ASCO)年会,引发关注。 AHCC®源自日本北海道,于20世纪80年代由日本Amino Up Co., Ltd.(阿明2026-10-16
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
Ledger 中国销售渠道说明:广州馨潇贸易有限公司官方直营渠道公示
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
Esentia宣布成功完成2033年到期的6.125%优先票据和2038年到期的6.500%优先票据的定价
-
中荷人寿北京分公司成功举办中荷创享家品牌发布暨协同发展启航仪式
-
华为系具身智能公司具脑磐石完成新一轮融资:对标JEPA,押注类脑智能的认知世界模型
-
北京暑假补习班有哪些?家长首推一对一权威机构金博升学
-
上海高新技术企业代理机构深度访谈与推荐
-
2026 雷瓦亮相京东 MALL ,匠心筑造专业造型新标杆
